# Comparison of Gadobutrol and Gadobenate Dimeglumin for Delayed Enhancement Cardiac MRI

> **NCT01655290** · PHASE2 · COMPLETED · sponsor: **Technical University of Munich** · enrollment: 20 (actual)

## Conditions studied

- Subacute/Chronic Myocardial Infarction

## Interventions

- **OTHER:** Gadovist® (Gadobutrol), Multihance® (Gadobenate dimeglumin)

## Key facts

- **NCT ID:** NCT01655290
- **Lead sponsor:** Technical University of Munich
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2013-05
- **Final completion:** 2014-06
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01655290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01655290, "Comparison of Gadobutrol and Gadobenate Dimeglumin for Delayed Enhancement Cardiac MRI". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01655290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*